Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB1, TRPV1, and PPAR<alpha>

Karwad, M.A. and Couch, D.G. and Wright, Karen and Tufarelli, C. and Larvin, M. and Lund, J. and O'Sullivan, S.E. (2019) Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB1, TRPV1, and PPAR<alpha>. Biochemical Pharmacology, 168. pp. 465-472. ISSN 0006-2952

[img] Text (Karward 2019)
Karward_2019.pdf - Accepted Version
Restricted to Repository staff only until 17 July 2020.
Available under License Creative Commons Attribution-NonCommercial-NoDerivs.

Download (412kB)

Abstract

Background and purpose We have previously reported that endocannabinoids modulate permeability in Caco-2 cells under inflammatory conditions and hypothesised in the present study that endocannabinoids could also modulate permeability in ischemia/reperfusion. Experimental approach Caco-2 cells were grown on cell culture inserts to confluence. Trans-epithelial electrical resistance (TEER) was used to measure permeability. To generate hypoxia (0% O2), a GasPak™ EZ anaerobe pouch system was used. Endocannabinoids were applied to the apical or basolateral membrane in the presence or absence of receptor antagonists. Key results Complete ypoxia decreased TEER (increased permeability) by ∼35% after 4 h (recoverable) and ∼50% after 6 h (non-recoverable). When applied either pre- or post-hypoxia, apical application of N-arachidonoyl-dopamine (NADA, via TRPV1), oleamide (OA, via TRPV1) and oleoylethanolamine (OEA, via TRPV1) inhibited the increase in permeability. Apical administration of anandamide (AEA) and 2-arachidonoylglycerol (2-AG) worsened the permeability effect of hypoxia (both via CB1). Basolateral application of NADA (via TRPV1), OA (via CB1 and TRPV1), noladin ether (NE, via PPARα), and palmitoylethanolamine (PEA, via PPARα) restored permeability after 4 h hypoxia, whereas OEA increased permeability (via PPARα). After 6 h hypoxia, where permeability does not recover, only basolateral application PEA sustainably decreased permeability, and NE decreased permeability. Conclusions and Implications A variety of endocannabinoids and endocannabinoid-like compounds modulate Caco-2 permeability in hypoxia/reoxygenation, which involves multiple targets, depending on whether the compounds are applied to the basolateral or apical membrane. CB1 antagonism and TRPV1 or PPARα agonism may represent novel therapeutic targets against several intestinal disorders associated with increased permeability.

Item Type: Journal Article
Journal or Publication Title: Biochemical Pharmacology
Additional Information: This is the author’s version of a work that was accepted for publication in Biochemical Pharmacology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Biochemical Pharmacology, 168, 2019 DOI: 10.1016/j.bcp.2019.07.017
Uncontrolled Keywords: /dk/atira/pure/subjectarea/asjc/3000/3004
Subjects:
Departments: Faculty of Health and Medicine > Biomedical & Life Sciences
ID Code: 135654
Deposited By: ep_importer_pure
Deposited On: 22 Jul 2019 12:50
Refereed?: Yes
Published?: Published
Last Modified: 11 Sep 2019 04:40
URI: https://eprints.lancs.ac.uk/id/eprint/135654

Actions (login required)

View Item View Item